These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2589268)

  • 1. On combination therapy with benzoate and piridoxilate.
    Cyr DM; Tremblay GC
    Am J Dis Child; 1989 Dec; 143(12):1392. PubMed ID: 2589268
    [No Abstract]   [Full Text] [Related]  

  • 2. Excretion of hippuric acid during sodium benzoate therapy in patients with hyperglycinaemia or hyperammonaemia.
    Barshop BA; Breuer J; Holm J; Leslie J; Nyhan WL
    J Inherit Metab Dis; 1989; 12(1):72-9. PubMed ID: 2501586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of lack of toxicity of sodium phenylacetate and sodium benzoate in treating urea cycle enzymopathies.
    Batshaw ML; Brusilow SW
    J Inherit Metab Dis; 1981; 4(4):231. PubMed ID: 6796778
    [No Abstract]   [Full Text] [Related]  

  • 4. Potentiation by piridoxilate of the synthesis of hippurate from benzoate in isolated rat hepatocytes. An approach to the determination of new pathways of nitrogen excretion in inborn errors of urea synthesis.
    Coude FX; Coude M; Grimber G; Pelet A; Charpentier C
    Clin Chim Acta; 1984 Jan; 136(2-3):211-7. PubMed ID: 6692575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzoylalanine: detection and identification of an alanine conjugate with benzoic acid in hyperammonemic patients treated with sodium benzoate.
    Shinka T; Inoue Y; Kuhara T; Matsumoto M; Matsumoto I
    Clin Chim Acta; 1985 Oct; 151(3):293-300. PubMed ID: 4053389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of long-term administration of sodium benzoate to a patient with partial ornithine carbamoyl transferase deficiency.
    Takeda E; Kuroda Y; Toshima K; Watanabe T; Naito E; Miyao M
    Clin Pediatr (Phila); 1983 Mar; 22(3):206-8. PubMed ID: 6825366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hyperammonemia with sodium benzoate.
    Kodama H; Kamoshita S; Motokawa Y
    J Pediatr; 1983 Sep; 103(3):498. PubMed ID: 6886925
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypocarnitinemia in patients affected by a primary defect of ammonia metabolism treated with sodium benzoate].
    Michalak A; Lambert MA; Dallaire L; Melançon SB; Laframboise R; Lemieux B; Qureshi IA
    Diabete Metab; 1990; 16(3):226-33. PubMed ID: 2210018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic benzoate therapy in a boy with partial ornithine transcarbamylase deficiency.
    Letarte J; Qureshi IA; Ouellet R; Godard M
    J Pediatr; 1985 May; 106(5):794-7. PubMed ID: 3998920
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of urea cycle disorders.
    Batshaw ML; Monahan PS
    Enzyme; 1987; 38(1-4):242-50. PubMed ID: 3326732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of urinary carnitine profile induced by benzoate administration.
    Sakuma T
    Arch Dis Child; 1991 Jul; 66(7):873-5. PubMed ID: 1863104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piridoxilate-associated nephrocalcinosis: a new form of chronic oxalate nephropathy.
    Vigeral P; Kenouch S; Chauveau D; Mougenot B; Méry JP
    Nephrol Dial Transplant; 1987; 2(4):275-8. PubMed ID: 3118272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hyperargininemia with sodium benzoate and arginine-restricted diet.
    Qureshi IA; Letarte J; Ouellet R; Batshaw ML; Brusilow S
    J Pediatr; 1984 Mar; 104(3):473-6. PubMed ID: 6707802
    [No Abstract]   [Full Text] [Related]  

  • 14. Nonlinear elimination of benzoate in patients with congenital hyperammonemia.
    Oyanagi K; Kuniya Y; Tsuchiyama A; Nakao T; Owada E; Sato J; Ito K
    J Pediatr; 1987 Apr; 110(4):634-6. PubMed ID: 3559815
    [No Abstract]   [Full Text] [Related]  

  • 15. Sodium benzoate and arginine: alternative pathway therapy in inborn errors of urea synthesis.
    Batshaw ML
    Prog Clin Biol Res; 1983; 127():69-83. PubMed ID: 6889404
    [No Abstract]   [Full Text] [Related]  

  • 16. The biochemistry and toxicology of benzoic acid metabolism and its relationship to the elimination of waste nitrogen.
    Tremblay GC; Qureshi IA
    Pharmacol Ther; 1993 Oct; 60(1):63-90. PubMed ID: 8127924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamyl glutamate prevents the potentiation of ammonia toxicity by sodium benzoate.
    O'Connor JE; Costell M; Grisolía S
    Eur J Pediatr; 1989 Apr; 148(6):540-2. PubMed ID: 2744016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of severe OTC deficiency.
    Brubakk AM; Teijema LL; Blom W; Berger R
    J Pediatr; 1982 Jun; 100(6):929-31. PubMed ID: 7086593
    [No Abstract]   [Full Text] [Related]  

  • 19. The potentiation of ammonia toxicity by sodium benzoate is prevented by L-carnitine.
    O'Connor JE; Costell M; Grisolía S
    Biochem Biophys Res Commun; 1987 Jun; 145(2):817-24. PubMed ID: 3593373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia.
    Van Hove JL; Kishnani P; Muenzer J; Wenstrup RJ; Summar ML; Brummond MR; Lachiewicz AM; Millington DS; Kahler SG
    Am J Med Genet; 1995 Dec; 59(4):444-53. PubMed ID: 8585564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.